Wednesday, July 9, 2025
HomeIndustriesHealthcare

Healthcare

Stealth BioTherapeutics Corp Announces Receipt of Preliminary Non-Binding Proposal

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, announced that...

Transgene and BioInvent Announce Positive Progress for BT-001

Transgene, a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”), a biotech company focused on the discovery...

Novel Pre-clinical Results Regarding Oncosec’s Intratumoral Electroporation Platform

OncoSec Medical Incorporated, a clinical-stage biotechnology company focused on developing intratumoral immunotherapies to stimulate the patient's own immune system to target and eradicate cancer,...

BioFluidica Next-Generation Liquid Biopsy Platform Uncovers Undiagnosed HER2+ Patients

Biofluidica announced the results of a breast cancer study comparing invasive needle biopsies with their non-invasive, highly sensitive Next-Generation Liquid Biopsy platform, LiquidScan™ to...

Antios Therapeutics’ ATI-2173 Demonstrates Suppression of Hepatitis B Virus in Phase 2a Study

Antios Therapeutics, Inc. (Antios), a clinical-stage biopharmaceutical company developing transformative treatments for hepatitis B virus (HBV), announced new data from the Phase 2a clinical...
0FansLike
0FollowersFollow
spot_img

Hot Topics